Cite Filings / STOK / 0001950047-25-009955
Feed Companies Filings Check
Sign in
144

Sale of Securities

Stoke Therapeutics, Inc. · Filed 2025-12-08 · Acc 0001950047-25-009955

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-03-02 144 Sale of Securities
  • 2025-12-10 4 GENERAL COUNSEL & CORP SEC sold 3,978 shares at an average $32.28 ($128,411)
  • 2025-12-10 4 Director sold 13,430 shares at an average $32.27 ($433,385)
  • 2025-12-08 144 Sale of Securities
  • 2025-12-08 144 Sale of Securities
  • 2025-12-05 4 GENERAL COUNSEL & CORP SEC sold 9,803 shares at an average $31.25 ($306,322)
  • 2025-12-05 4 CHIEF MEDICAL OFFICER sold 5,358 shares at an average $31.19 ($167,115)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…